Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Acta Anaesthesiol Scand ; 60(1): 117-27, 2016 Jan.
Article de Anglais | MEDLINE | ID: mdl-26355384

RÉSUMÉ

BACKGROUND: We hypothesize that pain and brain responses are affected by changes in the presentation sequence of noxious stimuli that are, overall, identical in intensity and duration. METHODS: During functional magnetic resonance imaging (fMRI) scanning, 21 participants experienced three patterns of noxious stimulation: Up-type (step-up noxious stimulation, 15 s), Down-type (step-down noxious stimulation, 15 s), and Down-up-type (decreasing and increasing pattern of noxious stimulation, 15 s). The total intensity and duration of the three noxious stimulation patterns were identical, but the stimulation sequences were different. RESULTS: Pain and unpleasantness ratings in the Down- and Down-up-type noxious stimulations were lower than in the Up-type noxious stimulation. The left prefrontal cortex [(PFC, BA (Brodmann area) 10, (-45, 50, 1)] was more highly activated in the Down- and Down-up-type noxious stimulations than in the Up-type noxious stimulation. The S1, S2, insula, bilateral PFC (BA 46), and midcingulate cortex were more highly activated in the Up-type noxious stimulation than in the Down-type noxious stimulation. PFC BA 10 was located at an inferior level compared to the bilateral PFC BA 46 (Z axis = 1 for BA 10, compared to 22 and 25 for the right and left BA 46, respectively). When cortisol level was increased, the left hippocampal cortex, along with the left parahippocampal cortex, was greatly activated for the Up-type noxious stimulation. CONCLUSION: When pain cannot be avoided in clinical practice, noxious stimuli should be applied to patients in a step-down pattern that delivers the most intense pain first and the least intense pain last.


Sujet(s)
Encéphale/physiopathologie , Perception de la douleur , Douleur/physiopathologie , Adulte , Femelle , Latéralité fonctionnelle , Gyrus du cingulum/physiopathologie , Hippocampe/physiopathologie , Température élevée , Humains , Hydrocortisone/sang , Imagerie par résonance magnétique , Mâle , Mesure de la douleur , Stimulation physique , Cortex préfrontal/physiopathologie , Testostérone/sang
2.
Zygote ; 9(3): 245-50, 2001 Aug.
Article de Anglais | MEDLINE | ID: mdl-11508744

RÉSUMÉ

The objective of this study was to determine whether porcine PAG (poPAG) genes are expressed in embryos as they develop from the 1-cell stage to expanded blastocysts, and whether expression differed according to how embryos had been derived. Embryos at various preimplantation stages were assayed after in vivo fertilisation, after in vitro fertilisation of in vitro-matured oocytes, or following parthenogenetic activation of in vitro-matured oocytes. The presence of PAG transcripts was determined at the 1-, 2-, and 4-cell, compact morula and blastocyst stages by reverse transcription-PCR procedures with PAG 1- and PAG 2-specific primers, followed by Southern blotting. The mRNAs for poPAG 1 and 2 were detected in in vitro-derived, in vivo-derived and parthenogenetically derived blastocyst stage embryos. In some replications poPAG 1 could be detected as early as the compact morula stage and poPAG 2 could be detected as early as the 4-cell stage. Our study revealed that poPAG 1 and 2 genes are expressed as early as the compact morula stage and 4-cell stage, respectively, in normal embryos and in parthenogenetically derived blastocysts. Thus it appears that the poPAGs are not maternally imprinted and they may be useful as potential candidates for markers of developmental competence.


Sujet(s)
Aspartic acid endopeptidases/biosynthèse , Embryon de mammifère/métabolisme , Protéines de la grossesse/biosynthèse , Animaux , Technique de Southern , Fécondation in vitro , Expression des gènes , Techniques in vitro , ARN/métabolisme , ARN messager/métabolisme , RT-PCR , Suidae , Facteurs temps
3.
Biol Reprod ; 61(4): 900-5, 1999 Oct.
Article de Anglais | MEDLINE | ID: mdl-10491622

RÉSUMÉ

This study was conducted to determine whether a protein tyrosine kinase (PTK) activity is involved in the initiation of the events that occur at fertilization in pig oocytes. After maturation for 47 h, a 7-h treatment of oocytes with 1 mM sodium orthovanadate, which is an inhibitor of protein tyrosine phosphatase, caused more than 90% pronuclear formation, cortical granule exocytosis, and a decrease in mitogen-activated protein kinase activity. Immunoblotting with an antibody specific for phosphotyrosine showed at least three proteins whose phosphotyrosine contents were significantly increased upon treatment of oocytes with 1 mM sodium orthovanadate. Preincubation of pig oocytes with 50 microM tyrphostin 47, a specific PTK inhibitor, completely blocked the ability of sodium orthovanadate to trigger activation events. In addition, when oocytes were pretreated with the calcium-chelating agent BAPTA-AM, sodium orthovanadate-stimulated pronuclear formation was significantly (P < 0.01) reduced (94.0% vs. 43.1%). These results suggest that PTK may be involved in pig oocyte activation in a calcium-dependent manner and that the stimulation of tyrosine kinase is able to signal a series of intracellular changes that lead to the activation events associated with fertilization.


Sujet(s)
Ovocytes/enzymologie , Parthénogenèse/effets des médicaments et des substances chimiques , Protein Tyrosine Phosphatases/antagonistes et inhibiteurs , Vanadates/pharmacologie , Animaux , Chélateurs/pharmacologie , Acide egtazique/analogues et dérivés , Acide egtazique/pharmacologie , Électrophorèse sur gel de polyacrylamide , Antienzymes/pharmacologie , Exocytose/effets des médicaments et des substances chimiques , Femelle , Fécondation in vitro/médecine vétérinaire , Mitogen-Activated Protein Kinases/métabolisme , Phosphorylation , Suidae , Tyrphostines/pharmacologie
4.
Biol Reprod ; 59(3): 655-60, 1998 Sep.
Article de Anglais | MEDLINE | ID: mdl-9716566

RÉSUMÉ

This study determined whether stimulation of a G protein-coupled receptor could initiate the events that occur at fertilization in pig oocytes and, if so, whether the activated oocytes were competent to form blastocysts. After maturation for 30 h, oocytes received microinjections of mRNA encoding the rat M1 muscarinic receptor, a G protein-coupled acetylcholine (ACh) receptor. Oocytes were then incubated for an additional 15 h to complete maturation of oocytes and translation of microinjected mRNA, and they were subsequently cultured in the presence of ACh. ACh treatment of these oocytes triggered pronuclear formation (50.4%) as well as cortical granule exocytosis. SDS-PAGE showed that mRNA-microinjected oocytes treated with ACh were activated (61.1%), as characterized by the appearance of the 22-kDa polypeptide derived from dephosphorylation of the 25-kDa precursor. Furthermore, after being cultured in a ligated pig oviduct for 6 days, 17.4% of treated oocytes developed to the compact morula or blastocyst stage. Transmission electron microscopy revealed that blastocysts recovered from ligated oviducts contained reticulated nucleoli with fibrillar cores surrounded by fibrillar and granular components. In addition, mitochondria in the blastocysts were dispersed throughout the cytoplasm and contained numerous transverse cristae. These results show that pig oocyte activation mediated by a G protein-coupled signal transduction system can signal a series of intracellular changes that lead to activation events associated with fertilization. Furthermore, oocytes activated through this pathway showed preimplantation development consistent with normal development.


Sujet(s)
Protéines G/physiologie , Ovocytes/physiologie , Récepteur muscarinique/physiologie , Suidae , Acétylcholine/pharmacologie , Animaux , Blastocyste/physiologie , Blastocyste/ultrastructure , Nucléole/ultrastructure , Femelle , Expression des gènes , Techniques de transfert de gènes , Microinjections , Microscopie électronique , Mitochondries/ultrastructure , Morula/physiologie , Ovocytes/ultrastructure , ARN messager/administration et posologie , Rats , Récepteur muscarinique de type M1 , Récepteur muscarinique/génétique , Transduction du signal
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...